Drawing for IDENTIGEN

USPTO serial 78057195

IDENTIGEN

Reviewed by CopyMark Law Group

Reg. 2869094Status 710
Filing date
Status date
Registration date
Aug 3, 2004
Examiner
MILTON, PRISCILLA
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with IDENTIGEN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Carolyn M. Sandberg

CAROLYN M SANDBERG LINDQUIST & VENNUM PLLP4200 IDS CTR 80 S EIGHTH STMINNEAPOLIS, MN 55402UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Chemical and biological diagnostic preparations and substances for in vitro use in laboratories and for analysis for use in drug discovery and protein therapeutics in the bio-pharmaceutical industrySECTION 8 - CANCELLED
005Pharmaceuticals using protein biotherapeutics to treat human diseases, namely, cancer, autoimmune disorders, infectious disease, cardiovascular disorders, metabolic disorders, neurological disorders; and for wound healing; chemical and biological diagnostic preparations and substances for clinical and medical laboratory use in drug discovery and protein therapeutics in the bio-pharmaceutical industrySECTION 8 - CANCELLED
040Custom manufacture and purification of recombinant proteins and of chemical and biological diagnostic preparations and substances for others for use in drug discovery and protein therapeutics in the bio-pharmaceutical industrySECTION 8 - CANCELLED
042Scientific and medical research and testing services, chemical laboratory services, namely, protein target profiling, analysis of protein function; evaluation of protein function, and technical consulting and advisory services relating thereto; all of the foregoing for use in drug discovery and protein therapeutics in the bio-pharmaceutical industrySECTION 8 - CANCELLED

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 4, 2011C8..CANCELLED SEC. 8 (6-YR)
Aug 3, 2004R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 11, 2004PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 21, 2004NPUBNOTICE OF PUBLICATION
Feb 25, 2004CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Feb 23, 20041.BDSec. 1(B) CLAIM DELETED
Feb 23, 2004GNEAEXAMINERS AMENDMENT E-MAILED
Jan 21, 2004CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 16, 2003CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 16, 2003MAILPAPER RECEIVED
Nov 3, 2003CFITCASE FILE IN TICRS
Oct 6, 2003UNPRUNRESPONSIVE/DUPLICATE PAPER RECEIVED
Oct 6, 2003MAILPAPER RECEIVED
Jul 15, 2003GNSIINQUIRY TO SUSPENSION E-MAILED
Jan 28, 2003CNSLLETTER OF SUSPENSION MAILED
Dec 31, 2002TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 13, 2002CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 13, 2002MAILPAPER RECEIVED
Oct 9, 2002DOCKASSIGNED TO EXAMINER
May 6, 2002GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Feb 26, 2002CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 27, 2001CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 15, 2001DOCKASSIGNED TO EXAMINER

Frequently asked questions

Related guidance